Heparin Dosing for Diagnostic Coronary Angiography
For diagnostic coronary angiography, administer 50-70 U/kg IV bolus of unfractionated heparin if glycoprotein IIb/IIIa inhibitors are planned, or 70-100 U/kg IV bolus if no GP IIb/IIIa inhibitors are planned, targeting an ACT of 200-250 seconds or 250-350 seconds respectively.
Weight-Based Dosing Strategy
The evidence strongly supports weight-based over fixed-dose heparin administration. The 2013 ACC/AHA STEMI guidelines provide Class I recommendations for weight-adjusted dosing during PCI 1. The 2011 ACC/AHA/SCAI PCI guidelines similarly endorse weight-based regimens, noting that this approach provides more predictable anticoagulation and avoids "overshooting" target ACT values 2.
Key dosing parameters:
- With GP IIb/IIIa inhibitors: 50-70 U/kg IV bolus, target ACT 200-250 seconds 1
- Without GP IIb/IIIa inhibitors: 70-100 U/kg IV bolus, target ACT 250-300 seconds (HemoTec) or 300-350 seconds (Hemochron) 1, 2
The 2012 ESC STEMI guidelines align with these recommendations, specifying 70-100 U/kg when no GP IIb/IIIa inhibitor is planned and 50-60 U/kg with GP IIb/IIIa inhibitors 3.
Monitoring Requirements
ACT monitoring is essential during the procedure. The FDA label specifies that dosing should be adjusted based on coagulation test results, with ACT being the preferred monitoring method during coronary procedures 4. Check ACT at baseline and adjust heparin boluses as needed to maintain therapeutic range 2.
Special Considerations for Radial Access
For transradial diagnostic angiography specifically, recent evidence suggests higher heparin doses reduce radial artery occlusion (RAO). The SPIRIT OF ARTEMIS trial demonstrated that 100 U/kg (administered in divided doses) reduced RAO to 3.0% versus 8.1% with 50 U/kg, without increasing bleeding 5. This represents an 80% reduction in RAO risk, with a number needed to treat of approximately 20 patients 5.
However, for purely diagnostic procedures via radial access without intervention, the standard 50-70 U/kg or 70-100 U/kg dosing based on GP IIb/IIIa use remains guideline-recommended. The higher 100 U/kg dosing from SPIRIT OF ARTEMIS represents emerging evidence but is not yet incorporated into major society guidelines.
Common Pitfalls to Avoid
Do not use fixed-dose heparin (e.g., 5000 units) for all patients. While a 2006 study showed safety with 5000 units 6, weight-based dosing provides superior anticoagulation control and earlier achievement of therapeutic levels. Fixed dosing fails to account for body size variability and may result in subtherapeutic anticoagulation in larger patients or excessive anticoagulation in smaller patients.
Do not administer heparin intramuscularly due to high risk of hematoma formation 4.
Do not continue routine heparin infusions post-procedure after uncomplicated diagnostic angiography, as this increases bleeding risk without proven benefit 6, 2.
Post-Procedure Management
Heparin is typically not reversed after diagnostic angiography 7. Remove femoral sheaths when ACT falls to 150-180 seconds or when aPTT falls to 50 seconds 2. For radial access, hemostasis protocols vary but typically involve 30-minute compression followed by stepwise release 8.
Alternative Dosing in Specific Contexts
The FDA label provides alternative regimens for cardiovascular surgery (≥150 U/kg, frequently 300-400 U/kg depending on procedure duration) 4, but these are not applicable to diagnostic angiography.
For patients with obesity (BMI ≥30), the 2024 ESC consensus statement recommends weight-based dosing without capping, though consideration of ideal body weight may prevent overdosing in severe obesity 9.